Results 71 to 80 of about 160 (95)

[Dose adjustment according to renal function in a polymedicated patient included in the medication reconditioning service using medication compliance aids (MCA)]. [PDF]

Farm Comunitarios
Barris Blundell D, Mousavi H.
europepmc   +1 more source

[Therapeutic drug option for dyslipaemia]. [PDF]

Aten Primaria, 2010
Maiques Galan A, Brotons Cuixart C.
europepmc   +1 more source

Rhabdomyolysis as a manifestation of clomipramine poisoning. [PDF]

Sao Paulo Med J, 2013
Santana NO, Góis AF.
europepmc   +1 more source

[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?] [PDF]

Semergen, 2020
Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL, Gorriz JL.   +4 more
europepmc   +1 more source

Prevalence of systemic complications of COVID-19 in critically ill patients: systematic review with meta-analysis. [PDF]

Rev Lat Am Enfermagem
Sawada NO, Reis TMD, Freitas PS, Moraes CM, Peloso-Carvalho BM, Assunção MRS, Horvath CMSP, Silva RS, Mendes KDS.   +8 more
europepmc   +1 more source

[Rhabdomyolysis induced by cerivastatin]. [PDF]

Aten Primaria, 2001
Hernanz Hernanz P, Rodríguez Hermida B, Sainza Rúa T, Ortega Inclán MN.   +3 more
europepmc   +1 more source

[Cerivastatin and gemfibrozil: a dangerous combination]. [PDF]

Aten Primaria, 2001
Tormo Molina J, Gázquez Pérez I, Matas Hoces A.   +2 more
europepmc   +1 more source

[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram]. [PDF]

Aten Primaria, 2004
Vich Pérez P, Ruiz Arribas C, Collados Navas R, Pastor-Sánchez R.   +3 more
europepmc   +1 more source